Literature DB >> 2208806

A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction.

M Kodama1, Y Matsumoto, M Fujiwara, F Masani, T Izumi, A Shibata.   

Abstract

It is suspected that autoimmune disease processes are involved in the pathogenesis of a part of giant cell myocarditis. However, evidence for autoimmunity has rarely been demonstrated in clinical investigations. In this study, we have demonstrated a new animal model of autoimmune myocarditis characterized by the appearance of multinucleated giant cells. Lewis rats were immunized twice with human cardiac myosin fraction in complete Freund's adjuvant. Cardiac myosin fraction was prepared from the ventricular muscle of human hearts. Three weeks after the first immunization, acute and severe myocarditis was elicited in all rats. This myocarditis was characterized by massive pericardial effusion, enlargement of the heart, and gray discoloration of the cardiac muscle. Microscopically, there was marked cellular infiltration consisting of mononuclear cells, neutrophils, fibroblasts, and a considerable number of multinucleated giant cells. Extensive myocardial necrosis was also present. The heart weights increased from the third week to the fourth week and then gradually decreased. The titer of anti-myosin antibodies began to elevate from the second week and remained high until the sixth week. In the sixth week, inflammation became smoldering and the multinucleated giant cells disappeared. These findings indicate that the cardiac myosin fraction contains myocarditogenic antigen and that giant cell myocarditis can be induced by autoimmune involvement. To our knowledge, this is the first report of experimental giant cell myocarditis, which is closely similar to human giant cell myocarditis in its histology and clinical course.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208806     DOI: 10.1016/0090-1229(90)90039-s

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  82 in total

Review 1.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Vahid Khalilzad-Sharghi; Zhongji Han; Shadi Othman; David Steffen; Jay Reddy
Journal:  Int J Cardiol       Date:  2015-09-18       Impact factor: 4.164

3.  Effects of zileuton on the development of autoimmune myocarditis in an experimental rat model.

Authors:  Ender Odemis; Sadi Turkay; Cemile Koca; Halil Kiyici; Ahmet Karadag; Reyhan Bayrak; Emin Mete; Ferhat Catal; Ramazan Yigitoglu
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

4.  IL-1 receptor accessory protein-Ig/IL-1 receptor type II-Ig heterodimer inhibits IL-1 response more strongly than other IL-1 blocking biopharmaceutical agents.

Authors:  Haruo Hanawa; Yoshimi Ota; Limin Ding; He Chang; Kaori Yoshida; Keita Otaki; Kazuhisa Hao; Sou Kasahara; Makoto Kodama; Mikio Nakazawa; Yoshifusa Aizawa
Journal:  J Clin Immunol       Date:  2010-12-22       Impact factor: 8.317

5.  Effect of hydrodynamics-based delivery of IL-18BP fusion gene on rat experimental autoimmune myocarditis.

Authors:  He Chang; Yan Wang; Gang Li; Le Zhang; Guang Wei Zhang; Yan Chun Liao; Haruo Hanawa; Jun Zou
Journal:  Clin Exp Med       Date:  2014-11       Impact factor: 3.984

6.  L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes.

Authors:  Taka-aki Okabe; Miki Hattori; Zuyi Yuan; Chiharu Kishimoto
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

7.  Acute hemodynamic and coronary circulatory effects of experimental autoimmune myocarditis.

Authors:  B J Friedman; O Y Grinberg; N R Ratcliffe; H M Swartz; W F Hickey
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

Review 8.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  FR167653 suppresses the progression of experimental autoimmune myocarditis.

Authors:  Seitaro Maruyama; Kiminori Kato; Makoto Kodama; Yuji Okura; Satoru Hirono; Koichi Fuse; Haruo Hanawa; Osamu Nakagawa; Mikio Nakazawa; Takashi Miida; Eisin Yaoita; Tadashi Yamamoto; Ikuo Inoue; Yoshifusa Aizawa
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

Review 10.  Tea polyphenols regulate key mediators on inflammatory cardiovascular diseases.

Authors:  Jun-ichi Suzuki; Mitsuaki Isobe; Ryuichi Morishita; Ryozo Nagai
Journal:  Mediators Inflamm       Date:  2009-07-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.